Hidenori Abe, Associate Professor of the Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tokushima University, is trying to develop a therapeutic drug that directly solves the root cause of renal dysfunction using the world's first "mini-kidney" that was successfully created independently. We are calling for donations through crowdfunding.
In July 2018, the International Society of Nephrology (ISN) released estimates that the number of patients with kidney disease worldwide is 7 million.However, the reality is that there is no real cure for kidney disease.The research group of Associate Professor Abe and others is aiming to develop a therapeutic drug that directly solves the root cause of renal dysfunction using the world's first mini-kidney that was successfully created independently.
A "mini kidney" is a basic device for blood filtration made outside the body.The original function of the kidney, "blood filtration," is a device that is only one-fifth the size of one mm in the two fist-sized left and right kidneys, and is performed constantly.This micro-sized blood filtration device is the center of the function of the kidney, and by making it outside the body, it is possible to establish a diagnosis and treatment method with less burden on the patient.If a drug that has the function of "protecting the kidney" can be found for this "mini kidney", it is also effective for actual kidney disease and can be used for early diagnosis, renal failure and dialysis. You will be able to perform treatment so that you do not reach.
The target amount of crowdfunding is 500 million yen. In order to find effective drugs for 8 million kidney disease patients, it is necessary to comprehensively analyze a huge small molecule library including therapeutic drugs for other diseases, and those drugs / compounds should be analyzed. Used to buy.Donations can be made from 5,000 yen and are being carried out on the crowdfunding site Otsucle until April 500, 2019.
